DBG
De Burlo Group Portfolio holdings
AUM
$759M
This Quarter Return
-0.92%
1 Year Return
+24.77%
3 Year Return
+146.35%
5 Year Return
+326.03%
10 Year Return
+1,922.48%
AUM
$537M
AUM Growth
+$537M
(-22%)
Cap. Flow
-$104M
Cap. Flow
% of AUM
-19.33%
Top 10 Holdings %
Top 10 Hldgs %
50.36%
Holding
184
New
91
Increased
12
Reduced
50
Closed
14
Top Buys
| 1 |
Amazon
AMZN
|
$18.8M |
| 2 |
UnitedHealth
UNH
|
$18.3M |
| 3 |
Vertex Pharmaceuticals
VRTX
|
$17.9M |
| 4 |
Berkshire Hathaway Class B
BRK.B
|
$17.4M |
| 5 |
Walt Disney
DIS
|
$16M |
Top Sells
| 1 |
Estee Lauder
EL
|
$18.2M |
| 2 |
Blackrock
BLK
|
$17.9M |
| 3 |
Danaher
DHR
|
$17.2M |
| 4 |
Linde
LIN
|
$17.2M |
| 5 |
EPAM Systems
EPAM
|
$16.3M |
Sector Composition
| 1 | Technology | 27.62% |
| 2 | Healthcare | 19.38% |
| 3 | Financials | 18.74% |
| 4 | Industrials | 8.98% |
| 5 | Communication Services | 8.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
151
Republic Services
RSG
$72.5B
| $8.35K | ﹤0.01% |
+63
| New | +$8.35K |
|
152
3M
MMM
$82B
| $7.44K | ﹤0.01% |
+50
| New | +$7.44K |
|
153
Capital One
COF
$143B
| $7.35K | ﹤0.01% |
+56
| New | +$7.35K |
|
154
Starbucks
SBUX
$101B
| $7.28K | ﹤0.01% |
+80
| New | +$7.28K |
|
155
Chubb
CB
$110B
| $7.06K | ﹤0.01% |
+33
| New | +$7.06K |
|
156
Intercontinental Exchange
ICE
$99.9B
| $6.21K | ﹤0.01% |
+47
| New | +$6.21K |
|
157
Sealed Air
SEE
$4.71B
| $6.09K | ﹤0.01% |
+91
| New | +$6.09K |
|
158
Honeywell
HON
$138B
| $5.84K | ﹤0.01% |
+30
| New | +$5.84K |
|
159
Arthur J. Gallagher & Co
AJG
$77.3B
| $5.76K | ﹤0.01% |
+33
| New | +$5.76K |
|
160
Ford
F
$46.6B
| $5.07K | ﹤0.01% |
+300
| New | +$5.07K |
|
161
GSK
GSK
$78.1B
| $4.36K | ﹤0.01% |
+100
| New | +$4.36K |
|
162
Novartis
NVS
$244B
| $4.12K | ﹤0.01% |
+47
| New | +$4.12K |
|
163
Eastman Chemical
EMN
$7.97B
| $3.7K | ﹤0.01% |
+33
| New | +$3.7K |
|
164
Comcast
CMCSA
$125B
| $3.18K | ﹤0.01% |
+68
| New | +$3.18K |
|
165
PPG Industries
PPG
$24.7B
| $3.15K | ﹤0.01% |
+24
| New | +$3.15K |
|
166
Myriad Genetics
MYGN
$629M
| $2.52K | ﹤0.01% |
+100
| New | +$2.52K |
|
167
EPR Properties
EPR
$4.05B
| $1.48K | ﹤0.01% |
+27
| New | +$1.48K |
|
|
CNCE
168
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
| $674 | ﹤0.01% |
+200
| New | +$674 |
|
|
FBRT
169
Franklin BSP Realty Trust
FBRT
$942M
| $671 | ﹤0.01% |
+48
| New | +$671 |
|
|
AGEN
170
Agenus
AGEN
$133M
| $246 | ﹤0.01% |
+100
| New | +$246 |
|
171
Agilent Technologies
A
$35B
| – | – |
-58,000
| Closed | -$9.26M |
|
172
ASML
ASML
$285B
| – | – |
-5,200
| Closed | -$4.14M |
|
173
Avantor
AVTR
$9.01B
| – | – |
-136,400
| Closed | -$5.75M |
|
174
Avery Dennison
AVY
$13.2B
| – | – |
-62,800
| Closed | -$13.6M |
|
175
CF Industries
CF
$14.1B
| – | – |
-67,500
| Closed | -$4.78M |
|